-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Anixa Biosciences Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
- Anixa Biosciences Inc Operating Income (Loss) for the quarter ending October 31, 2024 was -$3.16M, a 3.67% decline year-over-year.
- Anixa Biosciences Inc Operating Income (Loss) for the twelve months ending October 31, 2024 was -$13.8M, a 25.6% decline year-over-year.
- Anixa Biosciences Inc annual Operating Income (Loss) for 2024 was -$13.8M, a 25.6% decline from 2023.
- Anixa Biosciences Inc annual Operating Income (Loss) for 2023 was -$11M, a 20.6% increase from 2022.
- Anixa Biosciences Inc annual Operating Income (Loss) for 2022 was -$13.9M, a 5.63% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)